CD47 and cancer: Our further analysis of The Cancer Genome Atlas (TCGA) RNAseq data has identified several additional cancers, including lung adenocarcinoma and papillary thyroid carcinoma, that exhibit positive correlations between CD47 mRNA expression and patient survival but lack the CD47-associated immune signatures that were identified in melanomas.